β-globin gene transfer to human bone marrow for sickle cell disease-Reference-Cited by-同舟云学术

β-globin gene transfer to human bone marrow for sickle cell disease

Published:2013-07-01 Issue:8 Volume:123 Page:3317-3330
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Romero Zulema,Urbinati Fabrizia,Geiger Sabine,Cooper Aaron R.,Wherley Jennifer,Kaufman Michael L.,Hollis Roger P.,Ruiz de Assin Rafael,Senadheera Shantha,Sahagian Arineh,Jin Xiangyang,Gellis Alyse,Wang Xiaoyan,Gjertson David,DeOliveira Satiro,Kempert Pamela,Shupien Sally,Abdel-Azim Hisham,Walters Mark C.,Meiselman Herbert J.,Wenby Rosalinda B.,Gruber Theresa,Marder Victor,Coates Thomas D.,Kohn Donald B.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference69 articles.

1. Hoffman R Hematology: Basic Principles and Practice. 5th ed. London, United Kingdom: Churchill Livingstone; 2009.

2. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

3. Hemoglobin S gelation and sickle cell disease

4. Stamatoyannopoulos G Majerus PW Perlmutter RM Varmus H eds. Molecular Basis of Blood Diseases. 3rd ed. Philadelphia, Pennsylvania, USA: WB Saunders; 2001.

5. Blood and marrow transplantation for sickle cell disease: overcoming barriers to success

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapies on the horizon for sickle cell disease: a clinician’s perspective;Expert Review of Hematology;2024-07-31

2. A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell disease;Molecular Therapy - Methods & Clinical Development;2024-06

3. A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease mice;The Journal of Gene Medicine;2023-07-17

4. Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials;Viruses;2023-03-09

5. Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies;The CRISPR Journal;2023-02-01